Income Taxes (Details) - USD ($)	3 Months Ended	12 Months Ended
Dec. 31, 2025	Dec. 31, 2024	Sep. 30, 2025	Sep. 30, 2024
Income Taxes [Abstract]
Deferred income tax expense	$ 264,240	$ 264,240	$ 1,056,960	$ 576,000
Increased in valuation allowance			7,682,000	$ 4,928,000
Federal net operating loss carryforward			47,153,000
Federal research and development			$ 1,581,000

Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Subparagraph (b)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(1)(Note 1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (b)
-SubTopic 10
-Topic 740
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-9

Name:	us-gaap_DeferredIncomeTaxExpenseBenefit
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration